TrialHuman vaccines & immunotherapeutics2025

Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.

Daniela A Bota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.